Polsinelli Podcast - What You Need to Know About Public-Private Partnerships
Bribery & Corruption in the Military. A Front-Line View (Part II)
A Moment of Simple Justice - Vaccines
A Moment of Simple Justice - Felony Everything
How the Rise in Undercover Investigations is Changing the Law
A Moment of Simple Justice - A Prosecutor's Duty
Uncovering Factory Farming - The Effects of Ag Gag Laws
A Moment of Simple Justice - Undercover Lover
Trial by Jury: Why It Matters in a Democratic Society
Waldman: Stop Immunizing Websites That Allow Harassment
Busy Days For Voting Rights Advocates, Thanks to SCOTUS
A Moment of Simple Justice - Snitching Ain't Easy
Fighting for Education Rights: Equal Justice for Pregnant and Parenting Students
Combining Arms for Justice-Involved Veterans
A Moment of Simple Justice - Cameras on Cops
A Moment of Simple Justice - Ferguson
A Moment of Simple Justice - Revenge Porn
Schoenbrod: SCOTUS Ruling Helps EPA Deal With a "Stupid Statute"
SOX Whistleblower Protections Extend to Private Companies: Critical Steps to Take Now
A More Perfect Union: Why Punish Russia for Crimea?
In a recent opinion, a divided panel of the U.S. Court of Appeals for the Second Circuit ruled that an economic regulation passed by a state agency solely to protect one group from competition would not violate the...more
Friday’s ruling in Amarin Pharma, Inc. v. United States Food & Drug Administration is a monumental event. It signals the dawn of a new era for prescription drug promotion....more
In re Horizon Healthcare Services, Inc. Data Breach Litigation was a class action law suit arising out of the theft of two of Horizon’s password-protected laptops that contained the personal information of more than 839,000...more
On Feb. 25, 2015, nearly two years after argument, the South Carolina Supreme Court directed entry of a $136 million judgment against Janssen Pharmaceuticals Inc. These civil penalties stemmed from a suit brought by the...more
On Tuesday, the U.S. Food and Drug Administration (FDA) announced that it has reopened the comment period for its proposed rule on generic drug labeling. It has also scheduled a day-long public meeting to hear comments and...more
It is a very common practice. Drug sales reps visit a client, usually a hospital, a clinic or a doctor, with the sole purpose of selling a drug or medical device. That is the primary way a doctor learns about a drug or...more
We use the same methodology, that Ecofin-Oecd apply for projecting expenditure in the medium-long term, to reconstruct expenditure in the medium-long past.
It is possible to compare the effective expenditure with the...more
NFLPA Investigates Buccaneers on MRSA Issue
by Anthony Caruso on September 11, 2013
The Tampa Bay Buccaneers may be in hot water over whether the team communicated the outbreak of MRSA - a dangerous bacteria resistant...more
In United States v. Caronia, No. 09-5006-cr, slip op. (2d Cir. Dec. 3, 2012), the U.S. Court of Appeals for the Second Circuit held that "the government cannot prosecute pharmaceutical manufacturers and their representatives...more
Lo sviluppo delle copie economiche dei farmaci off-patent e il bottleneck della distribuzione al dettaglio. Brevi riflessioni sull'Italia...more
Nel dibattito che accompagna i tentativi di riforma degli esercizi farmaceutici e della distribuzione del farmaco si continua, in maniera pretestuosa, a far riferimento a un presunto contrasto tra da un lato le indicazioni...more
Il copay che può far bene alal sanità e al Federalismo (di Nicola C. Salerno)
data = 20 Dicembre 2010...more
All’indomani dell’audizione del Presidente dell’Agcm Antonio Catricalà in Commissione Igiene e Sanità del Senato, questo Wp fa il punto sullo stato della distribuzione al dettaglio del farmaco...more
Nel dibattito che accompagna i tentativi di riforma degli esercizi farmaceutici e della distribuzione del farmaco, si è aggiunto, negli ultimi tempi, un argomento nuovo.
Un presunto contrasto tra da un lato le...more
Recent developments in pre-emption law have outlined the requirements for bringing an action against a manufacturer of an FDA approved medical device. Specifically, devices that undergo the 510(k) approval process remain a...more
Court Upholds New Hampshire Prescription Privacy Law.
Today, the First Circuit Court of Appeals upheld a New Hampshire law that bans the sale of prescriber-identifiable prescription drug data for marketing purposes. In...more
Maine Prescription Privacy Law Struck Down.
In IMS v. Rowe, the Maine federal district court held that the state prescription privacy law violated the First Amendment. The court held that the Act improperly restricted the...more
EPIC Urges Court to Consider Privacy Interest in De-Identified Patient Data.
EPIC and 16 experts in privacy and technology today filed a "friend of the court" brief in a case concerning a New Hampshire state law banning...more
New Hampshire Files Brief in First Circuit Appeal of Ayotte.
New Hampshire has filed its brief in the First Circuit Court of Appeals seeking reversal of the federal district court's decision striking down the state...more
New Hampshire Prescription Privacy Law Struck Down.
In IMS v. Ayotte, the New Hampshire federal district court held that the state Prescription Confidentiality Act violated the First Amendment. The court held that the Act...more
Find a Constitutional Law Author »
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up to create your digest using LinkedIn*
Back to Top